TY - JOUR
T1 - Do antibacterial-coated sutures reduce wound infection in head and neck cancer reconstruction?
AU - Chen, Shih-Yi
AU - Chen, Tim-Mo
AU - Dai, Niann-Tzyy
AU - Fu, Ju-Peng
AU - Chang, Shun-Cheng
AU - Deng, Shou-Cheng
AU - Chen, Shyi-Gen
N1 - 被引用次數:16
Export Date: 21 March 2016
CODEN: EJSOE
通訊地址: Chen, S. G.; Department of Surgery, National Defense Medical Center, Tri-Service General Hospital, No. 325, Cheng-Gung Road, Taipei 11490, Taiwan; 電子郵件: [email protected]
化學物質/CAS: triclosan, 3380-34-5; Anti-Bacterial Agents; Anti-Infective Agents, Local; Polyglactin 910, 34346-01-5; Triclosan, 3380-34-5
商標: vicryl plus
參考文獻: Nuara, M.J., Sauder, C.L., Alam, D.S., Prospective analysis of outcomes and complications of 300 consecutive microvascular reconstructions (2009) Arch Facial Plast Surg, 11, pp. 235-239; Sanabria, A., Carvalho, A.L., Melo, R.L., Magrin, J., Ikeda, M.K., Vartanian, J.G., Kowalski, L.P., Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery (2008) Head and Neck, 30 (2), pp. 170-177. , DOI 10.1002/hed.20671; Lotfi, C.J., Cavalcanti, R.D.C., Silva, A.M.C.E., Dias De Oliveira Latorre, M.D.R., De Cassia Braga Ribeiro, K., Carvalho, A.L., Kowalski, L.P., Risk factors for surgical-site infections in head and neck cancer surgery (2008) Otolaryngology - Head and Neck Surgery, 138 (1), pp. 74-80. , DOI 10.1016/j.otohns.2007.09.018, PII S019459980701772X; Cohn, A.B., Lang, P.O., Agarwal, J.P., Free-flap reconstruction in the doubly irradiated patient population (2008) Plast Reconstr Surg, 122, pp. 125-132; Ogihara, H., Takeuchi, K., Majima, Y., Risk factors of postoperative infection in head and neck surgery (2009) Auris Nasus Larynx, 36, pp. 457-460; Robbins, K.T., Favrot, S., Hanna, D., Cole, R., Risk of wound infection in patients with head and neck cancer (1990) Head and Neck, 12 (2), pp. 143-148; Johnson, J.T., Myers, E.N., Sigler, B.A., Antimicrobial prophylaxis for contaminated head and neck surgery (1984) Laryngoscope, 94 (1), pp. 46-51; Marco, F., Vallez, R., Gonzalez, P., Ortega, L., De La Lama, J., Lopez-Duran, L., Study of the efficacy of Coated Vicryl Plus® antibacterial suture in an animal model of orthopedic surgery (2007) Surgical Infections, 8 (3), pp. 359-365. , DOI 10.1089/sur.2006.013; Edmiston, C.E., Seabrook, G.R., Goheen, M.P., Krepel, C.J., Johnson, C.P., Lewis, B.D., Brown, K.R., Towne, J.B., Bacterial Adherence to Surgical Sutures: Can Antibacterial-Coated Sutures Reduce the Risk of Microbial Contamination? (2006) Journal of the American College of Surgeons, 203 (4), pp. 481-489. , DOI 10.1016/j.jamcollsurg.2006.06.026, PII S1072751506010805; Rothenburger, S., Spangler, D., Bhende, S., Burkley, D., In vitro antimicrobial evaluation of coated VICRYL Plus antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assays (2002) Surg Infect (Larchmt), 3 (SUPPL. 1), pp. 79-S87; Justinger, C., Moussavian, M.R., Schlueter, C., Kopp, B., Kollmar, O., Schilling, M.K., Antibacterial [corrected] coating of abdominal closure sutures and wound infection (2009) Surgery, 145, pp. 330-334; Rozzelle, C.J., Leonardo, J., Li, V., Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: A prospective, double-blinded, randomized controlled trial (2008) J Neurosurg Pediatr, 2, pp. 111-117; Fleck, T., Moidl, R., Blacky, A., Fleck, M., Wolner, E., Grabenwoger, M., Wisser, W., Triclosan-Coated Sutures for the Reduction of Sternal Wound Infections: Economic Considerations (2007) Annals of Thoracic Surgery, 84 (1), pp. 232-236. , DOI 10.1016/j.athoracsur.2007.03.045, PII S0003497507006534; Coskun, H., Erisen, L., Basut, O., Factors affecting wound infection rates in head and neck surgery (2000) Otolaryngol Head Neck Surg, 123, pp. 328-333; Penel, N., Lefebvre, D., Fournier, C., Sarini, J., Kara, A., Lefebvre, J.-L., Risk factors for wound infection in head and neck cancer surgery: A prospective study (2001) Head and Neck, 23 (6), pp. 447-455. , DOI 10.1002/hed.1058; Jones, R.D., Jampani, H.B., Newman, J.L., Lee, A.S., Triclosan: A review of effectiveness and safety in health care settings (2000) American Journal of Infection Control, 28 (2), pp. 184-196; Slater-Radosti, C., Van Aller, G., Greenwood, R., Nicholas, R., Kellerb, P.M., DeWolf Jr., W.E., Fan, F., Jaworskia, D.D., Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus (2001) Journal of Antimicrobial Chemotherapy, 48 (1), pp. 1-6; McMurry, L.M., Oethinger, M., Levy, S.B., Triclosan targets lipid synthesis (1998) Nature, 394, pp. 531-532; Ming, X., Nichols, M., Rothenburger, S., In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan) (2007) Surg Infect (Larchmt), 8, pp. 209-214; Deliaert, A.E., Van Den Kerckhove, E., Tuinder, S., The effect of triclosan-coated sutures in wound healing. A double blind randomised prospective pilot study (2009) J Plast Reconstr Aesthet Surg, 62, pp. 771-773; Mingmalairak, C., Ungbhakorn, P., Paocharoen, V., Efficacy of antimicrobial coating suture coated polyglactin 910 with Tricosan (Vicryl plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report (2009) J Med Assoc Thai, 92, pp. 770-775; Ford, H.R., Jones, P., Gaines, B., Reblock, K., Simpkins, D.L., Intraoperative handling and wound healing: Controlled clinical trial comparing coated Vicryl® plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated Vicryl® suture (coated polyglactin 910 suture) (2005) Surgical Infections, 6 (3), pp. 313-321. , DOI 10.1089/sur.2005.6.313
PY - 2011
Y1 - 2011
N2 - Background: Surgical wound infection is a common complication, which increases the hospital stay and costs after surgery for head and neck cancer. In this study, we evaluated the effect of Triclosan-coated sutures on surgical wounds and analyzed the risk factors for wound infections in head and neck cancer surgery. Patients and Methods: From January 2007 to December 2009, 253 consecutive patients underwent wide excision of a head or neck cancer and reconstructive procedures. All patient data were collected prospectively. Of these, 241 patients were included in this study, divided into two groups. The Triclosan group contained 112 patients, whose surgical wounds were closed with Triclosan-coated sutures (Vicryl Plus). The control group included the remaining 129 patients, whose surgical wounds were closed with conventional Vicryl sutures. We conducted a retrospective, multivariate analysis to determine independent risk factors for the cervical wound infection. Results: The cervical wound infection rate was 14.9% (17/112) in the Triclosan group and 14.7% (19/129) in the control group, and these rates were not significantly different. Tumour stage and delayed intra-oral flap healing were independent risk factors for cervical wound infection. Conclusions: In this preliminary study, Triclosan-coated Vicryl sutures did not reduce the infection rate of cervical wounds after head or neck cancer surgery. The effectiveness of this suture material in head and neck cancer surgery should be considered with caution. © 2010 Elsevier B.V. All rights reserved.
AB - Background: Surgical wound infection is a common complication, which increases the hospital stay and costs after surgery for head and neck cancer. In this study, we evaluated the effect of Triclosan-coated sutures on surgical wounds and analyzed the risk factors for wound infections in head and neck cancer surgery. Patients and Methods: From January 2007 to December 2009, 253 consecutive patients underwent wide excision of a head or neck cancer and reconstructive procedures. All patient data were collected prospectively. Of these, 241 patients were included in this study, divided into two groups. The Triclosan group contained 112 patients, whose surgical wounds were closed with Triclosan-coated sutures (Vicryl Plus). The control group included the remaining 129 patients, whose surgical wounds were closed with conventional Vicryl sutures. We conducted a retrospective, multivariate analysis to determine independent risk factors for the cervical wound infection. Results: The cervical wound infection rate was 14.9% (17/112) in the Triclosan group and 14.7% (19/129) in the control group, and these rates were not significantly different. Tumour stage and delayed intra-oral flap healing were independent risk factors for cervical wound infection. Conclusions: In this preliminary study, Triclosan-coated Vicryl sutures did not reduce the infection rate of cervical wounds after head or neck cancer surgery. The effectiveness of this suture material in head and neck cancer surgery should be considered with caution. © 2010 Elsevier B.V. All rights reserved.
KW - Head and neck cancer reconstruction
KW - Triclosan-coated sutures
KW - Wound infection
KW - suture material
KW - triclosan
KW - adult
KW - antibacterial activity
KW - article
KW - cancer staging
KW - controlled study
KW - female
KW - head and neck cancer
KW - head and neck surgery
KW - human
KW - major clinical study
KW - male
KW - priority journal
KW - prospective study
KW - risk factor
KW - skin flap
KW - surgical infection
KW - surgical wound
KW - suture
KW - uterine cervicitis
KW - Adult
KW - Aged
KW - Anti-Bacterial Agents
KW - Anti-Infective Agents, Local
KW - Female
KW - Head and Neck Neoplasms
KW - Humans
KW - Male
KW - Middle Aged
KW - Multivariate Analysis
KW - Odds Ratio
KW - Patient Selection
KW - Polyglactin 910
KW - Prospective Studies
KW - Reconstructive Surgical Procedures
KW - Retrospective Studies
KW - Risk Factors
KW - Surgical Flaps
KW - Surgical Wound Infection
KW - Sutures
KW - Treatment Failure
KW - Triclosan
KW - Wound Healing
U2 - 10.1016/j.ejso.2011.01.015
DO - 10.1016/j.ejso.2011.01.015
M3 - Article
SN - 0748-7983
VL - 37
SP - 300
EP - 304
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 4
ER -